22-50525826-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001953.5(TYMP):​c.1393G>A​(p.Ala465Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0498 in 1,609,694 control chromosomes in the GnomAD database, including 2,263 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 145 hom., cov: 34)
Exomes 𝑓: 0.051 ( 2118 hom. )

Consequence

TYMP
NM_001953.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.495
Variant links:
Genes affected
TYMP (HGNC:3148): (thymidine phosphorylase) This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
SCO2 (HGNC:10604): (synthesis of cytochrome C oxidase 2) Cytochrome c oxidase (COX) catalyzes the transfer of electrons from cytochrome c to molecular oxygen, which helps to maintain the proton gradient across the inner mitochondrial membrane that is necessary for aerobic ATP production. Human COX is a multimeric protein complex that requires several assembly factors; this gene encodes one of the COX assembly factors. The encoded protein is a metallochaperone that is involved in the biogenesis of cytochrome c oxidase subunit II. Mutations in this gene are associated with fatal infantile encephalocardiomyopathy and myopia 6. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017577708).
BP6
Variant 22-50525826-C-T is Benign according to our data. Variant chr22-50525826-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 137878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-50525826-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMPNM_001953.5 linkc.1393G>A p.Ala465Thr missense_variant Exon 10 of 10 ENST00000252029.8 NP_001944.1 P19971-1E5KRG5
SCO2NM_005138.3 linkc.-368G>A upstream_gene_variant ENST00000395693.8 NP_005129.2 O43819

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMPENST00000252029.8 linkc.1393G>A p.Ala465Thr missense_variant Exon 10 of 10 1 NM_001953.5 ENSP00000252029.3 P19971-1
SCO2ENST00000395693.8 linkc.-368G>A upstream_gene_variant 1 NM_005138.3 ENSP00000379046.4 O43819

Frequencies

GnomAD3 genomes
AF:
0.0395
AC:
6011
AN:
152196
Hom.:
145
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0107
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.0345
Gnomad ASJ
AF:
0.0885
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0513
Gnomad FIN
AF:
0.0588
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.0542
Gnomad OTH
AF:
0.0406
GnomAD3 exomes
AF:
0.0459
AC:
10439
AN:
227524
Hom.:
340
AF XY:
0.0483
AC XY:
6106
AN XY:
126460
show subpopulations
Gnomad AFR exome
AF:
0.00963
Gnomad AMR exome
AF:
0.0275
Gnomad ASJ exome
AF:
0.0855
Gnomad EAS exome
AF:
0.000172
Gnomad SAS exome
AF:
0.0594
Gnomad FIN exome
AF:
0.0584
Gnomad NFE exome
AF:
0.0541
Gnomad OTH exome
AF:
0.0544
GnomAD4 exome
AF:
0.0508
AC:
74101
AN:
1457384
Hom.:
2118
Cov.:
37
AF XY:
0.0518
AC XY:
37532
AN XY:
724990
show subpopulations
Gnomad4 AFR exome
AF:
0.00980
Gnomad4 AMR exome
AF:
0.0289
Gnomad4 ASJ exome
AF:
0.0872
Gnomad4 EAS exome
AF:
0.000177
Gnomad4 SAS exome
AF:
0.0600
Gnomad4 FIN exome
AF:
0.0584
Gnomad4 NFE exome
AF:
0.0527
Gnomad4 OTH exome
AF:
0.0493
GnomAD4 genome
AF:
0.0395
AC:
6012
AN:
152310
Hom.:
145
Cov.:
34
AF XY:
0.0403
AC XY:
3002
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.0107
Gnomad4 AMR
AF:
0.0344
Gnomad4 ASJ
AF:
0.0885
Gnomad4 EAS
AF:
0.000772
Gnomad4 SAS
AF:
0.0519
Gnomad4 FIN
AF:
0.0588
Gnomad4 NFE
AF:
0.0542
Gnomad4 OTH
AF:
0.0402
Alfa
AF:
0.0424
Hom.:
101
Bravo
AF:
0.0364
TwinsUK
AF:
0.0585
AC:
217
ALSPAC
AF:
0.0457
AC:
176
ESP6500AA
AF:
0.0114
AC:
47
ESP6500EA
AF:
0.0513
AC:
417
ExAC
AF:
0.0441
AC:
5184
Asia WGS
AF:
0.0210
AC:
74
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mitochondrial DNA depletion syndrome 1 Benign:3
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mar 06, 2017
Counsyl
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Jul 18, 2011
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mitochondrial neurogastrointestinal encephalomyopathy Benign:1
Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

TYMP-related disorder Benign:1
Apr 01, 2021
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Fatal Infantile Cardioencephalomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.16
T;.;T;T;T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.75
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.54
.;T;.;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.8
L;.;L;L;.
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.14
N;N;N;N;N
REVEL
Benign
0.23
Sift
Benign
0.24
T;T;T;T;T
Sift4G
Benign
0.31
T;T;T;T;T
Polyphen
0.14
B;.;B;B;.
Vest4
0.055
MPC
0.45
ClinPred
0.014
T
GERP RS
2.3
Varity_R
0.17
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs112723255; hg19: chr22-50964255; COSMIC: COSV52687812; COSMIC: COSV52687812; API